ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

0RAM Vistin Pharma Asa

11.25
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Vistin Pharma Asa LSE:0RAM London Ordinary Share NO0010734122 VISTIN PHARMA ORD SHS
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 11.25 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 438.33M 45.64M 1.0293 10.93 498.88M

Vistin Pharma ASA: Key information relating to the proposed cash dividend

16/02/2024 9:30am

UK Regulatory


Vistin Pharma Asa (LSE:0RAM)
Historical Stock Chart


From Feb 2024 to May 2024

Click Here for more Vistin Pharma Asa Charts.
Vistin Pharma ASA: Key information relating to the proposed cash dividend

The Board of Directors of Vistin Pharma ASA plans to propose to distribute a cash dividend of total NOK 1.00 per share, to be paid partly in June and November, for the accounting year of 2023. The formal decision regarding the dividend will be made on the company's Annual General Meeting, which will be held on 23 May 2024.

Dividend amount (per share): NOK 0.50

Declared currency: NOK

Last day including right: 4 June 2024

Ex-date: 5 June 2024

Record date: 6 June 2024

Payment date (on or about): 18 June 2024

Date of approval: 23 May 2024


Dividend amount (per share): NOK 0.50

Declared currency: NOK

Last day including right: 5 November 2024

Ex-date: 6 November 2024

Record date: 7 November 2024

Payment date (on or about): 19 November 2024

Date of approval: 23 May 2024


This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.


For further information, please contact:

Alexander Karlsen

CFO

+47 97 05 36 21

alexander.karlsen@vistin.com

 


1 Year Vistin Pharma Asa Chart

1 Year Vistin Pharma Asa Chart

1 Month Vistin Pharma Asa Chart

1 Month Vistin Pharma Asa Chart

Your Recent History

Delayed Upgrade Clock